Boyd N F, Meakin J W, Hayward J L, Brown T C
Cancer. 1981 Aug 15;48(4):1037-42. doi: 10.1002/1097-0142(19810815)48:4<1037::aid-cncr2820480431>3.0.co;2-c.
To test the ability of the patient's history to provide prognostically important information in breast cancer the authors used information prospectively collected by interview from 756 patients enrolled in a randomized controlled trial of adjuvant therapy. Classification of this information according to the principles of rate of growth created groups with substantial and statistically significant differences in survival. The survival differences created by classifying growth rate were comparable to those created by other prognostic factors, and independent of those created by stage, lymph node status or tumor grade. The patient's history in breast cancer is capable of providing reproducible prognostic information when it is suitable classified, and this information represents a useful addition to current methods of estimating prognosis in breast cancer.
为了测试患者病史在乳腺癌中提供具有预后重要性信息的能力,作者使用了通过访谈前瞻性收集的756例参加辅助治疗随机对照试验患者的信息。根据生长速率原则对这些信息进行分类,创建了在生存率方面存在实质性且具有统计学显著差异的组。通过对生长速率进行分类所产生的生存差异与其他预后因素所产生的差异相当,并且独立于由分期、淋巴结状态或肿瘤分级所产生的差异。当对乳腺癌患者的病史进行适当分类时,它能够提供可重复的预后信息,并且该信息是对当前乳腺癌预后评估方法的有益补充。